Ochora, D.O.; Mogire, R.M.; Murithi, B.M.; Abdi, F.; Ondari, E.N.; Masai, R.J.; Mwakio, E.; Cheruyiot, A.; Yenesew, A.; Akala, H.M.
Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine. Pharmaceuticals 2025, 18, 956.
https://doi.org/10.3390/ph18070956
AMA Style
Ochora DO, Mogire RM, Murithi BM, Abdi F, Ondari EN, Masai RJ, Mwakio E, Cheruyiot A, Yenesew A, Akala HM.
Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine. Pharmaceuticals. 2025; 18(7):956.
https://doi.org/10.3390/ph18070956
Chicago/Turabian Style
Ochora, Douglas O., Reagan M. Mogire, Bernard M. Murithi, Farid Abdi, Erick N. Ondari, Rael J. Masai, Edwin Mwakio, Agnes Cheruyiot, Abiy Yenesew, and Hoseah M. Akala.
2025. "Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine" Pharmaceuticals 18, no. 7: 956.
https://doi.org/10.3390/ph18070956
APA Style
Ochora, D. O., Mogire, R. M., Murithi, B. M., Abdi, F., Ondari, E. N., Masai, R. J., Mwakio, E., Cheruyiot, A., Yenesew, A., & Akala, H. M.
(2025). Antimalarial Drug Repurposing of Epirubicin and Pelitinib in Combination with Artemether and Lumefantrine. Pharmaceuticals, 18(7), 956.
https://doi.org/10.3390/ph18070956